Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Matías Guiu

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Medicina Clinica|April 7, 1999
[Isotopic study with double phase 99mTc-sestamibi in the localization of parathyroid gland lesions]L Bernà, J Piera, J Rodríguez-Espinosa, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 10, 1998
A novel germline mutation in exon 5 of the multiple endocrine neoplasia type 1 geneA Chico, L Gallart, E Mato, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|January 5, 2000
Molecular pathology of multiple endocrine neoplasia type I: two novel germline mutations and updated classification of mutations affecting MEN1 geneJ M Martín-Campos, L Catasús, A Chico, et al.
Virchows Archiv : an International Journal of Pathology|December 5, 2019
Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)J Palacios, M de la Hoya, B Bellosillo, et al.
European Journal of Nuclear Medicine|November 3, 1998
Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinomaL Bernà, A Chico, X Matías-Guiu, et al.
Oncogene|September 18, 2007
Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological informationC Montero-Conde, J M Martín-Campos, E Lerma, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 23, 2001
Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type IA Chico, L Gallart, J M Martín-Campos, et al.
Medicina Clinica|June 22, 1999
[Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia]F J Pomares Gómez, M J Bernabé Espinosa, X Matías-Guiu Guía, et al.
British Journal of Cancer|June 20, 2022
M-CSF as a therapeutic target in BRAF<sup>V600E</sup> melanoma resistant to BRAF inhibitorsC Barceló, P Sisó, I de la Rosa, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 30, 1998
Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cellsI Carrió, P L Pieri, J Narula, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Medicina Clinica|April 7, 1999
[Isotopic study with double phase 99mTc-sestamibi in the localization of parathyroid gland lesions]L Bernà, J Piera, J Rodríguez-Espinosa, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 10, 1998
A novel germline mutation in exon 5 of the multiple endocrine neoplasia type 1 geneA Chico, L Gallart, E Mato, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|January 5, 2000
Molecular pathology of multiple endocrine neoplasia type I: two novel germline mutations and updated classification of mutations affecting MEN1 geneJ M Martín-Campos, L Catasús, A Chico, et al.
Virchows Archiv : an International Journal of Pathology|December 5, 2019
Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)J Palacios, M de la Hoya, B Bellosillo, et al.
European Journal of Nuclear Medicine|November 3, 1998
Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinomaL Bernà, A Chico, X Matías-Guiu, et al.
Oncogene|September 18, 2007
Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological informationC Montero-Conde, J M Martín-Campos, E Lerma, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 23, 2001
Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type IA Chico, L Gallart, J M Martín-Campos, et al.
Medicina Clinica|June 22, 1999
[Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia]F J Pomares Gómez, M J Bernabé Espinosa, X Matías-Guiu Guía, et al.
British Journal of Cancer|June 20, 2022
M-CSF as a therapeutic target in BRAF<sup>V600E</sup> melanoma resistant to BRAF inhibitorsC Barceló, P Sisó, I de la Rosa, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 30, 1998
Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cellsI Carrió, P L Pieri, J Narula, et al.
Pageof 5